Combined Photothermal Chemotherapy for Effective Treatment Against Breast Cancer in Mice Model
Junzi Chen,Yumin Xiang,Rong Bao,Yuyi Zheng,Yingxi Fang,Jiajia Feng,Di Wu,Xiaojie Chen
DOI: https://doi.org/10.2147/ijn.s473052
IF: 7.033
2024-09-29
International Journal of Nanomedicine
Abstract:Junzi Chen, &ast Yumin Xiang, &ast Rong Bao, Yuyi Zheng, Yingxi Fang, Jiajia Feng, Di Wu, Xiaojie Chen Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310053, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaojie Chen; Di Wu, Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, People's Republic of China, Email ; Introduction: Breast cancer ranks among the most prevalent cancers in women, characterized by significant morbidity, disability, and mortality. Presently, chemotherapy is the principal clinical approach for treating breast cancer; however, it is constrained by limited targeting capability and an inadequate therapeutic index. Photothermal therapy, as a non-invasive approach, offers the potential to be combined with chemotherapy to improve tumor cellular uptake and tissue penetration. In this research, a mesoporous polydopamine-coated gold nanorod nanoplatform, encapsulating doxorubicin (Au@mPDA@DOX), was developed. Methods: This nanoplatform was constructed by surface coating mesoporous polydopamine (mPDA) onto gold nanorods, and doxorubicin (DOX) was encapsulated in Au@mPDA owing to π-π stacking between mPDA and DOX. The dynamic diameter, zeta potential, absorbance, photothermal conversion ability, and drug release behavior were determined. The cellular uptake, cytotoxicity, deep penetration, and anti-tumor effects were subsequently investigated in 4T1 cells. After that, fluorescence imaging, photothermal imaging and pharmacodynamics studies were utilized to evaluate the anti-tumor effects in tumor-bearing mice model. Results: This nanoplatform exhibited high drug loading capacity, excellent photothermal conversion and, importantly, pH/photothermal dual-responsive drug release behavior. The in vitro results revealed enhanced photothermal-facilitated cellular uptake, drug release and tumor penetration of Au@mPDA@DOX under near-infrared irradiation. In vivo studies confirmed that, compared with monotherapy with either chemotherapy or photothermal therapy, the anti-tumor effects of Au@mPDA@DOX are synergistically improved. Conclusion: Together with good biosafety and biocompatibility, the Au@mPDA@DOX nanoplatform provides an alternative method for safe and synergistic treatment of breast cancer. Keywords: breast cancer, synergistic therapy, polydopamine, gold nanorod, chemotherapy Graphical Breast cancer is one of the most prevalent cancers among women and accounts for 31% of all new diagnoses, owing to its high morbidity, disability, and mortality. 1,2 Conventional treatments for breast cancer include surgery, chemotherapy, radiotherapy, etc. 3 Overall, chemotherapy is considered the standard strategy for treating breast cancer after surgical intervention. Doxorubicin (DOX), paclitaxel, and fluorouracil are widely utilized for clinical chemotherapy for breast cancer treatment and have good anti-tumor effects. 4 In particular, DOX is an effective chemotherapeutic agent for suppressing cancer cell growth via interference with DNA replication. 5,6 However, during long-term blood circulation, DOX molecules with phenolic structures under conventional medication routes can be quickly metabolized in the bloodstream or distributed around the tumor vasculature rather than penetrating into the tumor parenchyma. 7 Thus, low targeting efficiency requires a high medication dose, which may lead to potential adverse effects, such as gastrointestinal disorders, cardiac dysfunction, and drug resistance. 8 Thus, it is imperative to improve drug delivery efficiency to increase therapeutic efficacy and reduce potential adverse effects in the fight against breast cancer. Nanodrug delivery systems (NDDSs), which can endow therapeutics with increased stability, low toxicity, and enhanced anti-tumor functionalities, have received tremendous attention in cancer therapy. 9,10 Drug carriers at the nanoscale can passively accumulate at the tumor site via the enhanced permeability and retention (EPR) effect because of the high density and leaky vessels of solid tumors, as well as poor lymphatic drainage. 11–14 Unfortunately, a majority of NDDSs reach the tumor site and stagnate at the margin between tumor tissues and blood vessels. Tumor penetration of therapeutics -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology